Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG4 Multivalent Pneumococcal Vaccine Lot Consistency Study in Adults
NCT07794748Phase 3Recruiting
- Sponsor
- Pfizer
- Start
- Sep 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 3 trial of PG4 in pneumococcal disease, sponsored by Pfizer. Started Sep 2026; status: recruiting.
02
Drugs
PG4
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT07794748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07794748.